Vectors Research Management’s Adient ADNT Stock Holding History

Vectors Research Management’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-62	Closed	-$2K	–	141
2022 Q2	$2K	Buy	62 +1	+2%	+$34	﹤0.01%	460
2022 Q1	$2K	Sell	61 -85	-58%	-$3.65K	﹤0.01%	430
2021 Q4	$7K	Hold	146	–	–	﹤0.01%	462
2021 Q3	$6K	Hold	146	–	–	﹤0.01%	396
2021 Q2	$7K	Hold	146	–	–	﹤0.01%	414
2021 Q1	$6K	Sell	146 -3	-2%	-$113	﹤0.01%	369
2020 Q4	$5K	Sell	149 -20	-12%	-$564	﹤0.01%	371
2020 Q3	$3K	Buy	169 +12	+8%	+$209	﹤0.01%	364
2020 Q2	$3K	Sell	157 -16	-9%	-$243	﹤0.01%	369
2020 Q1	$2K	Sell	173 -12	-6%	-$242	﹤0.01%	417
2019 Q4	$4K	Buy	185 +19	+11%	+$421	﹤0.01%	430
2019 Q3	$4K	Hold	166	–	–	﹤0.01%	359
2019 Q2	$4K	Hold	166	–	–	﹤0.01%	328
2019 Q1	$2K	Hold	166	–	–	﹤0.01%	375
2018 Q4	$2K	Hold	166	–	–	﹤0.01%	589
2018 Q3	$8K	Buy	+166	New	+$7.48K	﹤0.01%	337

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

Greenvale Capital London, United Kingdom $916M AUM 32.73% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vectors Research Management's ADNT Position: Q3 2022 in Review

Vectors Research Management sold out of Adient (ADNT) in Q3 2022, closing a stake of 62 shares — an estimated $2K sold.

Vectors Research Management first reported a position in ADNT in Q3 2018 and held it in 16 quarters. The position peaked at $8K in Q3 2018. 248 funds tracked by Wall St. Rank hold ADNT as of Q3 2022.

Vectors Research Management reported no remaining Adient position as of Q3 2022 after selling out during the quarter.
Vectors Research Management sold 62 Adient shares in Q3 2022, an estimated $2K.
Vectors Research Management first reported a position in Adient in Q3 2018 and held it in 16 quarters.
Vectors Research Management's Adient position peaked at $8K in Q3 2018.
248 funds tracked by Wall St. Rank held Adient as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.